Form 8-K - Current report:
SEC Accession No. 0001641172-25-017723
Filing Date
2025-07-03
Accepted
2025-07-03 13:20:44
Documents
14
Period of Report
2025-07-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 47274
2 EX-10.1 ex10-1.htm EX-10.1 80583
3 EX-10.2 ex10-2.htm EX-10.2 111393
  Complete submission text file 0001641172-25-017723.txt   440369

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE nrxs-20250701.xsd EX-101.SCH 3014
5 XBRL LABEL FILE nrxs-20250701_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE nrxs-20250701_pre.xml EX-101.PRE 22358
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3790
Mailing Address 11611 N. MERIDIAN ST SUITE 330 CARMEL IN 46032
Business Address 11611 N. MERIDIAN ST SUITE 330 CARMEL IN 46032 (812) 689-0791
Neuraxis, INC (Filer) CIK: 0001933567 (see all company filings)

EIN.: 455079684 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41775 | Film No.: 251104760
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)